CG
BNGO icon

Cutler Group’s Bionano Genomics BNGO Stock Holding History

Cutler Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9
Closed -$1K – 3634
2023
Q3 		$1K Sell
9
-1
-10% -$262 ﹤0.01% 3429
2023
Q2 		$3K Hold
10
– – ﹤0.01% 2811
2023
Q1 		$6K Sell
10
-1
-9% -$888 ﹤0.01% 2602
2022
Q4 		$9K Hold
11
– – ﹤0.01% 2752
2022
Q3 		$12K Sell
11
-4
-27% -$5.29K ﹤0.01% 2966
2022
Q2 		$12K Buy
15
+1
+7% +$1.03K ﹤0.01% 3041
2022
Q1 		$21K Buy
14
+4
+40% +$5.4K ﹤0.01% 3002
2021
Q4 		$17K Buy
10
+1
+11% +$2.67K ﹤0.01% 3237
2021
Q3 		$30K Sell
9
-56
-86% -$196K ﹤0.01% 2959
2021
Q2 		$287K Sell
65
-201
-76% -$794K 0.01% 1085
2021
Q1 		$1.29M Buy
+266
New +$1.5M 0.06% 342

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cutler Group's BNGO Position: Q4 2023 in Review

Cutler Group sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 9 shares — an estimated $1K sold.

Cutler Group first reported a position in BNGO in Q1 2021 and held it in 11 quarters. The position peaked at $1.29M in Q1 2021. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

  • Cutler Group reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 9 Bionano Genomics shares in Q4 2023, an estimated $1K.
  • Cutler Group first reported a position in Bionano Genomics in Q1 2021 and held it in 11 quarters.
  • Cutler Group's Bionano Genomics position peaked at $1.29M in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.